Feedback form - Please send us Feedback
Breadcrumbs

Hugh Humphery, MD

Title
Assistant Professor, Department of Psychiatry & Behavioral Health
Office
AHC1 136
Phone
305.348.0477
Email
hugh.humphery@fiu.edu
Biography
Education:
1998   B.A. Biology, Lawrence University, Appleton, WI
2000   B.A. Chemistry, summa cum laude, Florida International University, Miami, FL
2005   M.D. Drexel University College of Medicine, Philadelphia, PA
2008   Residency in Adult Psychiatry, Duke University Medical Center, Durham, NC
2010   Chief Resident, in Child and Adolescent Psychiatry, Duke University Medical Center,                  
Durham, NC

Interests:
Clinical
2010-2011       Staff Psychiatrist, Psych Solutions, Inc., Miami, FL
2010-Present   Assistant Medical Director, Center for Children and Families, Florida International University, Miami, FL
2010-Present   President, Hugh Humphery M.D. LLC, Private Practice, Coral Gables, FL

Educational
2010-Present   Clinical Clerkship Supervision, Department of Psychiatry, FIU Herbert Wertheim College of Medicine
2010-Present   Psychiatric consultant to the Neighborhood Help Program, FIU Herbert Wertheim College of Medicine

Research
2009, Clinician
“Antidepressant Safety in Kids (ASK Study)”, Child and Adolescent Psychiatry Trials Network (CAPTN), Durham, NC. Open-label, prospective cohort study of antidepressants in children and adolescents with anxiety disorders, depressive disorders, eating disorders, and obsessive-compulsive disorder.

2009, Clinician
“New Versus Old Treatments for ADHD (NOTA Study)” CAPTN, Durham, NC. Open-label randomized study of MTS, Lisdexamfetime Dimesylate, OROS MPH and Mixed Amphetamine Salts ER in children and adolescents with ADHD.

2010, Clinician
“Parent Training and Social Skills Group for Children”, 3-C, Durham, NC. Study comparing a social skills group intervention to (SS GRIN) with a Parent Training component.

Present, Co-Investigator
“A Novel Multimodal Intervention for Children with ADHD and Impaired Mood”.  Goal is to evaluate a novel group-based therapy intervention for children with ADHD and impaired mood and to examine the safety of stimulants in children with ADHD and manic-like symptoms.

Present, Co-Investigator
NIMH submitted R01 entitled “A Novel Approach to Stimulant-Induced Weight Suppression and its Impact on Growth.” Study on growth suppression and rescue strategies after prolonged ER stimulant exposure.

Present, Co-Investigator
“Does Pharmacological Treatment of ADHD in Adults Enhance Parenting Performance?” The goal is to evaluate the impact of stimulant treatment of ADHD symptoms in adults on parenting capacity using a laboratory based assessment.